Floatz logo

Flecainide

Atrial Arrhythmia

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Atrial Arrhythmia cohort.

Asset / SponsorPhaseRating
Atropine
Medical University of Vienna
Phase 4BB
WARFARIN
Massachusetts General Hospital
Phase 3BB
HUMAN RELAXIN 1
Deeptankar DeMazumder
Phase 1/2CCC
PROPOFOL
4th Military Clinical Hospital with Polyclinic, Poland
N/AD
Rocuronium
4th Military Clinical Hospital with Polyclinic, Poland
N/AD

Same molecule, other indications

Flecainide is also rated in:

patent foramen ovaleDormant
B
Indicative ·
60 / 100
View asset →
ischemic strokeDormant
B
Indicative ·
60 / 100
View asset →
PainDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →